The P2X7 purinergic receptor: From physiology to neurological disorders

FASEB Journal

Volumn 24, Issue 2, 2010, Pages 337-345

  Skaper, Stephen D ^a   Debetto, Patrizia ^a   Giusti, Pietro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

ATP; Chronic pain; Cytokines; Depression; Inflammation; Microglia; Neurodegeneration

Indexed keywords

A 438079; A 740003; ANTINOCICEPTIVE AGENT; CATION CHANNEL; GSK 314181A; INTERLEUKIN 1BETA; PURINERGIC P2X7 RECEPTOR; RECEPTOR SUBTYPE; SODIUM ION; UNCLASSIFIED DRUG; 3' O (4 BENZOYL)BENZOYLADENOSINE 5' TRIPHOSPHATE; 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYTOKINE; DRUG DERIVATIVE; PURINERGIC P2 RECEPTOR;

CALCIUM TRANSPORT; CHRONIC INFLAMMATION; CHRONIC PAIN; CYTOKINE RELEASE; DEPRESSION; DNA POLYMORPHISM; EXCITATORY POSTSYNAPTIC POTENTIAL; HEMATOPOIETIC CELL; HUMAN; IMMUNE SYSTEM; INFLAMMATORY DISEASE; LYMPHOCYTE; MACROPHAGE; MICROGLIA; MOLECULAR WEIGHT; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROPATHY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; METABOLISM; MOUSE; NERVE CELL; PAIN; PHYSIOLOGY; RAT;

MUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; CYTOKINES; DEPRESSION; HUMANS; MICE; NERVOUS SYSTEM DISEASES; NEURONS; PAIN; RATS; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 76149099290     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-138883     Document Type: Review

References (113)

1. North, R. A. (2002) Molecular physiology of P2X receptors. Physiol. Rev. 82, 1013-1067
2. Burnstock, G. (2004) Introduction: P2 receptors. Curr. Top. Med. Chem. 4, 793-803
3. Khakh, B. S., and North, R. A. (2006) P2X receptors as cell-surface ATP sensors in health and disease. Nature 442, 527-532
4. North, R. A., and Surprenant, A. (2006) Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol. 40, 563-580
5. Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., and Buell, G. (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272, 735-738
6. Collo, G., Neidhart, S., Kawashima, E., Kosco-Vilbois, M., North, R. A., and Buell, G. (1997) Tissue distribution of the P2X7 receptor. Neuropharmacology 36, 1277-1283
7. Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi- Castagnoli, P., and Di Virgilio, F. (1996) Mouse microglia cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156, 1531-1539
8. 7 receptor expression in rodent brain. J. Neurosci. 24, 6307-6314
9. 7 receptor function and immunoreactivity in neurons. Trends Neurosci. 29, 257-262
10. 7 receptor antagonists/interleukin-1β inhibitors. J. Med. Chem. 50, 5882-5885
11. 7 antagonists. J. Med. Chem. 51, 3030-3034
12. 7 antagonist, dose dependently reduces neuropathic pain in the rat. J. Pharmacol. Exp. Ther. 319, 1376-1385
13. 7 receptors in non-neuronal cells of rat dorsal root ganglion. Brain Res. 1052, 63-70
14. Ferrari, D., Chiozzi, P., Falzoni, S., Dal Susino, M., Melchiorri, L., Baricordi, O. R., and Di Virgilio, F. (1997) Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159, 1451-1458
15. Ferrari, D., Chiozzi, P., Falzoni, S., Hanau, S., and Di Virgilio, F. (1997) Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185, 579-582
16. 7 receptor channels. J. Neurosci. 22, 3061-3069
17. Filippini, A., Taffs, R. E., Agui, T., and Sitkovsky, M. V. (1990) Ecto-ATPase activity in cytolytic T-lymphocytes. Protection from the cytolytic effects of extracellular ATP. J. Biol. Chem. 265, 334-340
18. 7- independent mechanism. J. Immunol. 163, 558-561
19. Ferrari, D., Chiozzi, P., Falzoni, S., Dal Susino, M., Collo, G., Buell, G., and Di Virgilio, F. (1997) ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36, 1295-1301
20. Beigi, R., Kobatake, E., Aizawa, M., and Dubyak, G. R. (1999) Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am. J. Physiol. Cell Physiol. 276, C267-C278
21. Dubyak, G. R., and el-Moatassim, C. (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. Cell Physiol 265, C577-C606
22. Lazarowski, E. R., Boucher, R. C., and Harden, T. K. (2000) Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J. Biol. Chem. 275, 31061-31068
23. Nieber, K., Eschke, D., and Brand, E. (1999) Brain hypoxia: effects of ATP and adenosine. Prog. Brain Res. 120, 287-297
24. 7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J. Leukoc. Biol. 64, 265-273
25. 7 receptor expression and function in human astrocytes. Glia 49, 245-258
26. Humphreys, B. D., Rice, J., Kertesy, S. B., and Dubyak, G. R. (2000) Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J. Biol. Chem. 275, 26792-26798
27. 7. J. Leukoc. Biol. 72, 222-232
28. Potucek, Y. D., Crain, J. M., and Watters, J. J. (2006) Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression. Neurochem. Internatl. 49, 204-214
29. 7/ P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J. Biol. Chem. 274, 13205-13210
30. 7 receptor in immune cells of the brain and periphery. J. Biol. Chem. 276, 23262-23267
31. 7 receptors. J. Biol. Chem. 278, 37344-37351
32. Aga, M., Watters, J. J., Pfeiffer, Z. A., Wiepz, G. J., Sommer, J. A., and Bertics, P. J. (2004) Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-κB signaling pathways in murine RAW 264.7 macrophages. Am. J. Physiol. Cell Physiol. 286, C923-C930
33. Pfeiffer, Z. A., Aga, M., Prabhu, U., Watters, J. J., Hall, D. J., and Bertics, P. J. (2004) The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J. Leukoc. Biol. 75, 1173-1182
34. MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., and Surprenant, A. (2001) Rapid secretion of interleukin-1β by microvesicle shedding. Immunity 8, 825-835
35. 2+ signaling in glial cell pathology in the central nervous system. Eur. J. Pharmacol. 447, 247-260
36. 7 receptor function and indicates a role in chronic pain states. Eur. J. Pharmacol. 447, 247-260
37. 7 receptors. J. Biol. Chem. 276, 125-132
38. 7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168, 6436-6445
39. 7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114, 386-396
40. 7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278, 13309-13317
41. 7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behav. Brain. Res. 198, 83-90
42. Allan, S. M., and Rothwell, N. J. (2001) Cytokines and acute neurodegeneration. Nat. Neurosci. 2, 734-744
43. 2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J. Biol. Chem. 273, 28670-28676
44. 7 receptormediated IL-1β release. J. Neurochem. 106, 271-280
45. 7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 10, 821-827
46. Keane, R. W., Davis, A. R., and Dietrich, W. D. (2006) Inflammatory and apoptotic signaling after spinal cord injury. J. Neurotrauma. 23, 335-344
47. 7 receptors on microglial cells mediate injury to cortical neurons in vitro. Glia 54, 234-242
48. 7 receptor expression after ischemia in the cerebral cortex of rats. J. Neuropathol. Exp. Neurol. 63, 686-699
49. Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., and Anand, P. (2006) COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurology 6, 12 (doi: 10.1186/1471-2377-6-12)
50. Volanté, C., Amadio, S., Cavaliere, F., D'Ambrosi, N., Vacca, F., and Bernardi, G. (2003) Extracellular ATP and neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 2, 403-412
51. Honda, S., Sasaki, Y., Ohsawa, K., Imai, Y., Nakamura, Y., Inoue, K., and Kohsaka, S. (2001) Extracellular ATP and ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J. Neurosci. 21, 1975-1982
52. Verderio, C., and Matteoli, M. (2001) ATP mediates calcium signalling between astrocytes and microglial cells: modulation by IFN-γ. J. Immunol. 166, 6383-6391
53. Burnstock, G., and Wood, J. N. (1996) Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr. Opin. Neurobiol. 6, 526-532
54. Fields, R. D., and Burnstock, G. (2006) Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 7, 423-436
55. Jahr, C. E., and Jessell, T. M. (1983) ATP excites a subpopulation of rat dorsal horn neurones. Nature 304, 730-733
56. Werry, E. L., Liu, G. J., and Bennett, M. R. (2006) Glutamate-stimulated ATP release from spinal cord astrocytes is potentiated by substance P. J. Neurochem. 99, 924-936
57. Raghavendra, V., and DeLeo, J. A. (2004) The role of astrocytes and microglia in persistent pain. Adv. Mol. Cell. Biol. 31, 951-966
58. Milligan, E. D., Maier, S. F., and Watkins, L. R. (2003) Review: Neuronal-glial interactions in central sensitization. Sem. Pain Med. 1, 171-183
59. Costigan, M., and Woolf, C. J. (2000) Pain: molecular mechanisms: J. Pain 1, 35-44
60. Touzani, O., Boutin, H., LeFeuvre, R., Parker, L., Miller, A., Luheshi, G., and Rothwell, N. (2002) Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type 1 receptor. J. Neurosci. 22, 38-43
61. Safieh-Garabedian, B., Poole, S., Allchorne, A., Winter, J., and Woolf, C. J. (1995) Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol. 115, 1265-1275
62. Sommer, C., Petrausch, S., Lindenlaub, T., and Toyka, K. V. (1999) Neutralizing antibodies to interleukin 1-receptor reduce pain-associated behavior in mice with experimental neuropathy. Neurosci. Lett. 270, 25-28
63. 7 receptor is not the only target. Br. J. Pharmacol. 140, 441-443
64. 2Z/ P2X7 antagonist, oxidized ATP, in arthritic rats. Neurosci. Lett. 327, 87-90
65. Evans, R. J., Lewis, C., Buell, G., Valera, S., North, R. A., and Surprenant, A. (1995) Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol. Pharmacol. 48, 178-183
66. 7 receptor antagonists. Bioorg. Med. Chem. Lett. 15, 435-438
67. 7 antagonists. J. Med. Chem. 49, 3659-3666
68. 7 antagonists. Bioorg. Med. Chem. Lett. 17, 4044-4048
69. McGaraughty, S., Chu, K. L., Namovic, M. T., Donnelly-Roberts, D. L., Harris, R. R., Zhang, X.-F., Shieh, C.-C., Wismer, C. T., Zhu, C. Z., Gauvin, D. M., Fabiyi, A. C., Honore, P., Gregg, R. J., Kort, M. E., Nelson, D. W., Carroll, W. A., Marsh, K., Faltynek, C. R., and Jarvis, M. F. (2007) P2X7-related modulation of pathological nociception in rats. Neuroscience 146, 1817-1828
70. 7 antagonist in animal models of pain and inflammation. J. Pharmacol. Exp. Ther. 327, 620-633
71. Smith, R. S. (1991) The macrophage theory of depression. Med. Hypotheses 35, 298-306
72. Anisman, H., Merali, Z., Poulter, M. O., and Hayley, S. (2005) Cytokines as a precipitant of depressive illness: animal and human studies. Curr. Pharm. Des. 11, 963-972
73. Larson, S. J., and Dunn, A. J. (2001) Behavioral effects of cytokines. Brain Behav. Immun. 15, 371-387
74. Pollak, Y., and Yirmiya, R. (2002) Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition,' immunotherapy and antidepressive treatment. Int. J. Neuropsychopharmacol. 5, 389-399
75. Wichers, M., and Maes, M. (2002) The psychoneuroimmune-pathophysiology of cytokine-induced depression in humans. Int. J. Neuropsychopharmacol. 5, 375-388
76. Kraus, M. R., Schäfer, A., Faller, H., Csef, H., and Scheurlen, M. (2002) Paroxetine for the treatment of interferon-α-induced depression in chronic hepatitis C. Aliment. Pharmacol. Ther. 16, 1091-1099
77. Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H. G., and Bogerts, B. (2006) Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 42, 151-157
78. Raison, C. L., Capuron, L., and Miller, A. H. (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27, 24-31
79. Tuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., and Abay, E. (2003) Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 170, 429-433
80. Alesci, S., Martinez, P. E., Kelkar, S., Ilias, I., Ronsaville, D. S., Listwak, S. J., Ayala, A. R., Licinio, J., Gold, H. K., Kling, M. A., Chrousos, G. P., and Gold, P. W. (2005) Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J. Clin. Endocrinol. Metab. 90, 2522-2530
81. Simen, B. B., Duman, C. H., Simen, A. A., and Duman, R. S. (2006) TNFα signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol. Psychiatry 59, 775-785
82. Barden, N., Harvey, M., Gagné, B., Shink, E., Tremblay, M., Raymond, C., Labbé, M., Villeneuve, A., Rochette, D., Bordeleau, L., Stadler, H., Holsboer, F., and Müller-Myhsok, B. (2006) Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am. J. Med. Genet. B 141, 374-382
83. Lucae, S., Salyakina, D., Barden, N., Harvey, M., Gagné, B., Labbé, M., Binder, E. B., Uhr, M., Paez-Pereda, M., Sillaber, I., Ising, M., Brückl, T., Lieb, R., Holsboer, F., and Müller-Myhsok, B. (2006) P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum. Mol. Genet. 15, 2438-2445
84. 7 gene: a dimensional approach. Am. J. Med. Genet. B 150, 295-299
85. 7 receptor. J. Biol. Chem. 278, 17108-17113
86. 7 nucleotide receptor polymorphisms by a novel monocyte pore assay predictive of alterations in lipopolysaccharide-induced cytokine production. J. Immunol. 174, 4424-4431
87. Maes, M. (2001) The immunoregulatory effects of antidepressants. Hum. Psychopharmacol. 16, 95-103
88. Xia, Z., DePierre, J. W., and Nässberger, L. (1996) Tricyclic antidepressants inhibit IL-6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T cells. Immunopharmacology 34, 27-37
89. Brustolim, D., Ribeiro-dos-Santos, R., Kast, R. E., Altschuler, E. L., and Soares, M. B. P. (2006) A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferongamma in mice. Int. Immunopharmacol. 6, 903-907
90. Yirmiya, R., Pollak, Y., Barak, O., Avitsur, R., Ovadia, H., Bette, M., Weihe, E., and Weidenfeld, J. (2001) Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24, 531-544
91. Lanquillon, S., Krieg, J.-C., Bening-Abu-Shach, U., and Vedder, H. (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22, 370-379
92. Egan, T. M., Samways, D. S., and Li, Z. (2006) Biophysics of P2X receptors. Pflügers Archiv. 452, 501-512
93. 7R)-induced pore formation in human THP-1 cells. J. Pharmacol. Exp. Ther. 308, 1053-1061
94. 7 receptor. EMBO J. 25, 5071-5082
95. Dubyak, G. R. (2007) Go it alone no more-P2X7 joins the society of heteromeric ATP-gated receptor channels. Mol. Pharmacol. 72, 1402-1405
96. 7 heteromeric receptors. Mol. Pharmacol. 72, 1447-1456
97. Raouf, R., Chabot-Doré, A.-J., Ase, A. R., Blais, D., and Séguéla, P. (2007) Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation. Neuropharmacology 53, 496-504
98. Korcok, J., Raimundo, L. N., Ke, H. Z., Sims, S. M., and Dixon, S. J. (2004) Extracellular nucleotides act through P2X7 receptors to activate NF-κB in osteoclasts. J. Bone Miner. Res. 19, 642-651
99. 4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778-783
100. Torres, G. E., Egan, T. M., and Voigt, M. M. (1999) Heterooligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J. Biol. Chem. 274, 6653-6659
101. Nicke, A. (2008) Homotrimeric complexes are the dominant assembly state of native P2X7 subunits. Biochem. Biophys. Res. Commun. 377, 803-808
102. 7 receptor signalling complex. EMBO J. 20, 6347-6358
103. 7 receptor C terminus. J. Biol. Chem. 277, 34017-34023
104. 7 ATP channel. Biochem. Biophys. Res. Commun. 332, 17-27
105. 7 pore. J. Neurosci. 29, 3781-3791
106. Chen, Y., Zhang, X., Wang, C., Li, G. W., Gu, Y., and Huang, L.-Y. M. (2008) Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons. Proc. Natl. Acad. Sci. U. S. A. 105, 16773-16778
107. 7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J. Neurosci. 21, 7143-7152
108. 7 receptors in the nervous system. Prog. Neurobiol. 78, 327-346
109. Witting, A., Chen, L., Cudaback, E., Straiker, A., Walter, L., Rickman, B., Möller, T., Brosnan, C., and Stella, N. (2006) Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc. Natl. Acad. Sci. U. S. A. 103, 6362-6367
110. 3H]2-cyano-1-[(1S)-1-phenylethyl]-3- quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors. Neuropharmacology 56, 223-229
111. Honore, P., Donnelly-Roberts, D., Namovic, M., Zhong, C., Wade, C., Chandran, P., Zhu, C., Carroll, W., Perez-Medrano, A., Iwakura, Y., and Jarvis, M. F. (2009) The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1αβ knockout mice. Behav. Brain Res. 204, 77-81
112. Palomino-Doza, J., Rahman, T. J., Avery, P. J., Mayosi, B. M., Farrall, M., Watkins, H., Edwards, C. R. W., and Keavney, B. (2008) Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes. Hypertension 52, 980-985
113. Ralevic, V., and Burnstock, G. (2003) Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect. 16, 133-140